UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

Annals of neurology, 1998-09, Vol.44 (S1), p.S115-S120

1998

Volltextzugriff (PDF)

Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects

Neurology, 2004-12, Vol.63 (12), p.2413-2415

2004

Volltextzugriff (PDF)

Nitric oxide synthase and neuronal vulnerability in parkinson's disease

Neuroscience, 1996-05, Vol.72 (2), p.355-363

1996

Volltextzugriff (PDF)

Blood vessels change in the mesencephalon of patients with Parkinson's disease

The Lancet (British edition), 1999-03, Vol.353 (9157), p.981-982

1999

Volltextzugriff (PDF)

Caspase-3: A Vulnerability Factor and Final Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (6), p.2875-2880

2000

Volltextzugriff (PDF)

Preservation of midbrain catecholaminergic neurons in very old human subjects

Brain (London, England : 1878), 2000-02, Vol.123 (2), p.366-373

2000

Volltextzugriff (PDF)

Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes

Human molecular genetics, 1997-10, Vol.6 (11), p.1771-1780

1997

Volltextzugriff (PDF)

Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases

American journal of neuroradiology : AJNR, 2010-08, Vol.31 (7), p.1311-1318

2010

Volltextzugriff (PDF)

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

Journal of Neural Transmission, 2005-09, Vol.112 (9), p.1237-1248

2005

Volltextzugriff (PDF)

Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis

The Journal of neuroscience, 2001-04, Vol.21 (7), p.2247-2255

2001

Volltextzugriff (PDF)

Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes

Neuropathology and applied neurobiology, 2011-08, Vol.37 (5), p.500-512

2011

Volltextzugriff (PDF)

Iron metabolism and Parkinson's disease

Movement disorders, 1998, Vol.13, p.39-45

1998

Volltextzugriff (PDF)

FADD: A link between TNF family receptors and caspases in Parkinson's disease

Neurology, 2002-01, Vol.58 (2), p.308-310

2002

Volltextzugriff (PDF)

Expression of Lactoferrin Receptors is Increased in the Mesencephalon of Patients with Parkinson Disease

Proceedings of the National Academy of Sciences - PNAS, 1995-10, Vol.92 (21), p.9603-9607

1995

Volltextzugriff (PDF)

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Journal of neurochemistry, 2001-03, Vol.76 (6), p.1785-1793

2001

Volltextzugriff (PDF)

Wernicke encephalopathy and Creutzfeldt-Jakob disease

Journal of neurology, 2009-06, Vol.256 (6), p.904-909

2009

Volltextzugriff (PDF)

Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements

The European journal of neuroscience, 2000-01, Vol.12 (1), p.337-344

2000

Volltextzugriff (PDF)

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease

Neuroscience, 1999-02, Vol.88 (4), p.1015-1032

1999

Volltextzugriff (PDF)

Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases

Acta neuropathologica, 1996, Vol.91 (6), p.566-572

1996

Volltextzugriff (PDF)

Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain-definition and evaluation of new MRI-based ratios

IEEE transactions on medical imaging, 2006-08, Vol.25 (8), p.1052-1067

2006

Volltextzugriff (PDF)

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study

Neuroscience, 1996-04, Vol.71 (4), p.903-912

1996

Volltextzugriff (PDF)

trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients : An in situ hybridization study

Neuroscience, 1998-10, Vol.86 (3), p.813-826

1998

Volltextzugriff (PDF)

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

Brain research, 1995-09, Vol.692 (1), p.233-243

1995

Volltextzugriff (PDF)

FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

The Journal of neuroscience, 1999-05, Vol.19 (9), p.3440-3447

1999

Volltextzugriff (PDF)

Expression of tachykinin NK2 receptor mRNA in human brain

Neuroscience letters, 2001-04, Vol.303 (1), p.25-28

2001

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Englisch
(155)
Französisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects

Nitric oxide synthase and neuronal vulnerability in parkinson's disease

Blood vessels change in the mesencephalon of patients with Parkinson's disease

Caspase-3: A Vulnerability Factor and Final Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease

Preservation of midbrain catecholaminergic neurons in very old human subjects

Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes

Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis

Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes

Iron metabolism and Parkinson's disease

FADD: A link between TNF family receptors and caspases in Parkinson's disease

Expression of Lactoferrin Receptors is Increased in the Mesencephalon of Patients with Parkinson Disease

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Wernicke encephalopathy and Creutzfeldt-Jakob disease

Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements

An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease

Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases

Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain-definition and evaluation of new MRI-based ratios

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study

trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients : An in situ hybridization study

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine

FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

Expression of tachykinin NK2 receptor mRNA in human brain

Suchergebnisse filtern